Tivic Health Systems, Inc. financial data

Symbol
TIVC on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
47685 Lakeview Blvd, Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 467 % +32.4%
Quick Ratio 80.9 % +51%
Debt-to-equity 29 % -35.8%
Return On Equity -172 % +15.8%
Return On Assets -133 % +5.27%
Operating Margin -601 % +5.92%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.18M shares -95.8%
Common Stock, Shares, Outstanding 6.18M shares -79.2%
Entity Public Float 3M USD -76.9%
Common Stock, Value, Issued 1K USD -66.7%
Weighted Average Number of Shares Outstanding, Basic 4.01M shares +1251%
Weighted Average Number of Shares Outstanding, Diluted 4.01M shares +1251%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.11M USD -21.7%
Cost of Revenue 803K USD -29.7%
Research and Development Expense 1.26M USD -29.9%
Selling and Marketing Expense 1.93M USD +1.8%
General and Administrative Expense 3.82M USD -32.7%
Operating Income (Loss) -6.69M USD +26.3%
Nonoperating Income (Expense) -60K USD
Net Income (Loss) Attributable to Parent -6.75M USD +25.7%
Earnings Per Share, Basic 5.95 USD/shares +95.5%
Earnings Per Share, Diluted 5.95 USD/shares +95.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.69M USD +38.9%
Accounts Receivable, after Allowance for Credit Loss, Current 16K USD +23.1%
Inventory, Net 766K USD -22.5%
Assets, Current 4.66M USD +16.6%
Property, Plant and Equipment, Net 120K USD -3.23%
Operating Lease, Right-of-Use Asset 304K USD -36.8%
Other Assets, Noncurrent 34K USD 0%
Assets 4.78M USD +4.07%
Accounts Payable, Current 446K USD -46.3%
Employee-related Liabilities, Current 70K USD
Liabilities, Current 591K USD -49.1%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 591K USD -58.8%
Retained Earnings (Accumulated Deficit) -40.6M USD -19.9%
Stockholders' Equity Attributable to Parent 4.19M USD +32.6%
Liabilities and Equity 4.78M USD +4.07%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.67M USD +31.3%
Net Cash Provided by (Used in) Financing Activities -61K USD -101%
Net Cash Provided by (Used in) Investing Activities -94K USD -1467%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 6.18M shares -79.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.73M USD -205%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.69M USD +38.9%
Deferred Tax Assets, Valuation Allowance 7.57M USD +4.9%
Deferred Tax Assets, Gross 7.67M USD +4.18%
Operating Lease, Liability 321K USD -36.4%
Depreciation 1K USD -50%
Payments to Acquire Property, Plant, and Equipment 94K USD +1467%
Lessee, Operating Lease, Liability, to be Paid 335K USD -38.3%
Property, Plant and Equipment, Gross 159K USD
Operating Lease, Liability, Current 180K USD -1.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 210K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 178K USD -15.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14K USD -63.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 178K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 6.76M USD +3.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 98K USD -14.8%
Operating Lease, Payments 189K USD -3.08%
Additional Paid in Capital 44.8M USD +21%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1K USD -66.7%
Deferred Tax Assets, Net of Valuation Allowance 97K USD -32.2%
Share-based Payment Arrangement, Expense 214K USD -45.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%